research use only
Cat.No.: F5016
| Dilution |
|---|
|
| Application |
|---|
| WB |
| Reactivity |
|---|
| Human, Mouse, Rat |
| Source |
|---|
| Rabbit Monoclonal Antibody |
| Storage Buffer |
|---|
| PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3 |
| Storage (from the date of receipt) |
|---|
| -20°C (avoid freeze-thaw cycles), 2 years |
| Predicted MW |
|---|
| 130-150 kDa |
| Positive Control | HUVEC cells; A431 cells; C2C12 cells; PANC-1 cells; C6 cells; SHSY5Y cells |
|---|---|
| Negative Control |
| WB |
|---|
Experimental Protocol:
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature. 2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min. 4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip"; 4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications Recommended conditions for wet transfer: 200 mA, 120 min. ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight; 2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. |
| Specificity |
|---|
| Pan-Cadherin Antibody [J6A2] detects endogenous levels of total Pan-Cadherin protein. |
| Subcellular Location |
|---|
| Cell membrane, Cell junction |
| Uniprot ID |
|---|
| P19022, P22223, P12830, P55283 |
| Clone |
|---|
| J6A2 |
| Synonym(s) |
|---|
| ACOGS; Arc-1; ARVD14; BCDS1; CAD4; CADH1; CADH2; CADH3; CADH4; Cadherin; cadherin 1; cadherin 1, E-cadherin (epithelial); cadherin 1, type 1; cadherin 1, type 1, E-cadherin (epithelial); cadherin 2 |
| Background |
|---|
| Pan-cadherin refers to antibodies recognizing conserved extracellular cadherin (EC) domains across classical cadherins (E-, N-, P-, VE-cadherin), which are single-pass transmembrane glycoproteins mediating Ca²⁺-dependent homophilic cell-cell adhesion critical for tissue morphogenesis, barrier integrity, and junctional signaling. Each cadherin monomer features a prodomain-cleaved N-terminus, five tandem EC repeats (~110-residue β-sandwich Greek-key topology with Ca²⁺-binding sites at EC1-2/EC2-3/EC3-4 linkers that rigidify the rod-like ectodomain into a ~90° curve), a single-span transmembrane helix, and a conserved cytoplasmic tail that recruits p120-catenin, β-catenin, α-catenin, and plakoglobin to anchor junctions to F-actin. It exhibits zipper-like adhesion: EC1 N-terminal strand-swap (Trp2 strand βB insertion into partner EC1 acceptor pocket) forms trans-homophilic bonds (~10⁻⁷ M affinity) requiring Ca²⁺-induced rigidity, while lateral cis-dimerization via the EC1 hydrophobic patch and EC4 interface clusters ~200 cadherins per junction μm. Catenin-mediated tension transduction activates YAP/β-catenin signaling and Rho GTPase contractility (yielding ~2-fold cortical tension increase). Pan-cadherin enforces epithelial polarity (apical adherens junctions), endothelial barrier function (VE-cadherin mechanosensing), neuronal layering (N-cadherin synapse stabilization), and EMT suppression (E-cadherin loss leads to N-cadherin switch). Cadherin switch (E-cadherin↓/N-cadherin↑) drives invasion in ~80% of carcinomas via MMP9/FGFR cooperation; mutations underlie congenital heart defects (HLHS), blinding dystrophies (P-cadherin), and tumor metastasis, while therapeutic cadherin mimetics can restore barrier function in inflammatory diseases. |
| References |
|---|
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.